Compounds > n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea

Page last updated: 2024-09-03

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Neutropenia

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea has been researched along with Neutropenia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chollet, P; Cure, H; D'Incan, M; Durando, X; Madelmont, JC; Mouret-Reynier, MA; Souteyrand, P; Thivat, E	1
Adenis, A; Chevallier, B; Chollet, P; Fumoleau, P; Kerbrat, P; Krakowski, I; Lentz, MA; Rebattu, P; Roche, H	1
Adenis, A; Chevallier, B; Chollet, P; Curé, H; Fumoleau, P; Kerbrat, P; Krakowski, I; Lentz, MA; Roché, H; Tubiana, N	1
Adenis, A; Chollet, P; Cure, H; Fargeot, P; Fumoleau, P; Hanausk, A; Lentz, MA; Madelmont, JC; Roche, H; Terret, C	1

Trials

4 trial(s) available for n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Neutropenia

Article	Year
Second-line chemotherapy of disseminated malignant melanoma with cystemustine at 60 mg/m2: a phase II trial. Anti-cancer drugs, 2005, Volume: 16, Issue:9 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Female; Humans; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Neutropenia; Nitrosourea Compounds; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting	2005
Phase II study of cystemustine in metastatic colorectal carcinoma. A trial of the EORTC Clinical Screening Group. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Female; Humans; Male; Middle Aged; Neutropenia; Nitrosourea Compounds; Thrombocytopenia; Treatment Outcome	1993
Results of a phase II trial with second-line cystemustine at 60 mg/m2 in advanced soft tissue sarcoma: a trial of the EORTC Early Clinical Studies Group. European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Male; Middle Aged; Neutropenia; Nitrosourea Compounds; Sarcoma; Thrombocytopenia; Treatment Failure	1998
Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adults. Journal of neuro-oncology, 2000, Volume: 49, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Female; Glioblastoma; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Nitrosourea Compounds; Thrombocytopenia; Tomography, X-Ray Computed	2000